Naja kaouthia - Venom Bibliography

1:
Kukhtina VV, Weise C, Muranova TA, Starkov VG, Franke P, Hucho F, Wnendt S, Gillen C, Tsetlin VI, Utkin YN.
Muscarinic toxin-like proteins from cobra venom.
Eur J Biochem. 2000 Dec;267(23):6784-9.

2:
Okumura K, Inoue S, Ohkura N, Ikeda K, Hayashi K.
cDNA cloning of the two subunits of phospholipase A2 inhibitor PLIgamma from blood plasma of the Chinese mamushi, Agkistrodon blomhoffii siniticus.
IUBMB Life. 1999 Jul;48(1):99-104.

3:
Chuman Y, Nobuhisa I, Ogawa T, Deshimaru M, Chijiwa T, Tan NH, Fukumaki Y, Shimohigashi Y, Ducancel F, Boulain JC, Menez A, Ohno M.
Regional and accelerated molecular evolution in group I snake venom gland phospholipase A2 isozymes.
Toxicon. 2000 Mar;38(3):449-62.

4:
Antil S, Servent D, Menez A.
Variability among the sites by which curaremimetic toxins bind to torpedo acetylcholine receptor, as revealed by identification of the functional residues of alpha-cobratoxin.
J Biol Chem. 1999 Dec 3;274(49):34851-8.

5:
Khow O, Wongtongkam N, Pakmanee N, Omori-Satoh T, Sitprija V.
Development of reversed passive latex agglutination for detection of Thai cobra (Naja kaouthia) venom.
J Nat Toxins. 1999 Jun;8(2):213-20.

6:
Okumura K, Masui K, Inoue S, Ikeda K, Hayashi K.
Purification, characterization and cDNA cloning of a phospholipase A2 inhibitor from the serum of the non-venomous snake Elaphe quadrivirgata.
Biochem J. 1999 Jul 1;341 ( Pt 1):165-71.

7:
Ohkura N, Kitahara Y, Inoue S, Ikeda K, Hayashi K.
Isolation and amino acid sequence of a phospholipase A2 inhibitor from the blood plasma of the sea krait, Laticauda semifasciata.
J Biochem (Tokyo). 1999 Feb;125(2):375-82.

8:
Hamako J, Matsui T, Nishida S, Nomura S, Fujimura Y, Ito M, Ozeki Y, Titani K.
Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naha kaouthia cobra venom.
Thromb Haemost. 1998 Sep;80(3):499-505.

9:
Saetang T, Suttijitpaisal P, Ratanabanangkoon K.
Preparations of toxic components from Naja kaouthia venom by selective heat denaturation.
J Nat Toxins. 1998 Feb;7(1):37-44.

10:
Pakmanee N, Khow O, Kumsap W, Omori-Satoh T, Chanhome L, Sriprapat S, Sitprija V.
Envenomation of mice by Thai cobra (Naja kaouthia) venom: tolerable venom concentration and exposure time.
Toxicon. 1998 May;36(5):809-12.

11:
Wang X, Buck F, Havsteen B.
Elucidation of a new biological function of an old protein: unique structure of the cobra serum albumin controls its specific toxin binding activity.
Int J Biochem Cell Biol. 1998 Feb;30(2):225-33.

12:
Alam MI, Gomes A.
An experimental study on evaluation of chemical antagonists induced snake venom neutralization.
Indian J Med Res. 1998 Mar;107:142-6.

13:
Chanhome L, Cox MJ, Wilde H, Jintakoon P, Chaiyabutr N, Sitprija V.
Venomous snakebite in Thailand. I: Medically important snakes.
Mil Med. 1998 May;163(5):310-7. Review.

14:
Pe T, Myint T, Htut A, Htut T, Myint AA, Aung NN.
Envenoming by Chinese krait (Bungarus multicinctus) and banded krait (B. fasciatus) in Myanmar.
Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):686-8.

15:
Khow O, Pakmanee N, Chanhome L, Sriprapat S, Omori-Satoh T, Sitprija V.
Cross-neutralization of Thai cobra (Naja kaouthia) and spitting cobra (Naja siamensis) venoms by Thai cobra antivenom.

Toxicon. 1997 Nov;35(11):1649-51.

16:
Pratanaphon R, Akesowan S, Khow O, Sriprapat S, Ratanabanangkoon K.
Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia).
Vaccine. 1997 Oct;15(14):1523-8.

17:
Ringler P, Kessler P, Menez A, Brisson A.
Purification of the nicotinic acetylcholine receptor protein by affinity chromatography using a regioselectively modified and reversibly immobilized alpha-toxin from Naja nigricollis.
Biochim Biophys Acta. 1997 Feb 21;1324(1):37-46.

18:
Gold BS.
Neostigmine for the treatment of neurotoxicity following envenomation by the Asiatic cobra.
Ann Emerg Med. 1996 Jul;28(1):87-9.

19:
Fletcher JE, Jiang MS.
Presynaptically acting snake venom phospholipase A2 enzymes attack unique substrates.
Toxicon. 1995 Dec;33(12):1565-76.

20:
Rodrigues-Simioni L, Prado-Franceschi J, Cintra AC, Giglio JR, Jiang MS, Fletcher JE.
No role for enzymatic activity or dantrolene-sensitive Ca2+ stores in the muscular effects of bothropstoxin, a Lys49 phospholipase A2 myotoxin.
Toxicon. 1995 Nov;33(11):1479-89.

21:
Wang X, Havsteen B, Hansen H.
Evidence of the coevolution of a snake toxin and its endogenous antitoxin cloning, sequence and expression of a serum albumin cDNA of the Chinese cobra.
Biol Chem Hoppe Seyler. 1995 Sep;376(9):545-53.

22:
Fletcher JE, Storella RJ, Jiang MS.
Bovine serum albumin does not completely block synaptosomal cholinergic activities of presynaptically acting snake venom phospholipase A2 enzymes.
Toxicon. 1995 Aug;33(8):1051-60.

23:
Wall J, Golding CA, Van Veen M, O’Shea P.
The use of fluoresceinphosphatidylethanolamine (FPE) as a real-time probe for peptide-membrane interactions.
Mol Membr Biol. 1995 Apr-Jun;12(2):183-92.

24:
Sells PG, Theakston RD, Warrell DA.
Development of alpha-neurotoxin antibodies in patients envenomed by the monocellate Thai cobra (Naja kaouthia).
Toxicon. 1994 Dec;32(12):1667-71. Review.

25:
Sells PG, Jones RG, Laing GD, Smith DC, Theakston RD.
Experimental evaluation of ovine antisera to Thai cobra (Naja kaouthia) venom and its alpha-neurotoxin.
Toxicon. 1994 Dec;32(12):1657-65.

26:
Ohkura N, Inoue S, Ikeda K, Hayashi K.
The two subunits of a phospholipase A2 inhibitor from the plasma of Thailand cobra having structural similarity to urokinase-type plasminogen activator receptor and LY-6 related proteins.
Biochem Biophys Res Commun. 1994 Nov 15;204(3):1212-8.

27:
Stiles BG, Sexton FW, Guest SB, Olson MA, Hack DC.
Characterization of monoclonal antibodies against Naja naja oxiana neurotoxin I.
Biochem J. 1994 Oct 1;303 ( Pt 1):163-70.

28:
Schlottmann K, Gulbins E, Rauterberg EW, Steinhausen M.
Effects of systemic complement activation on renal circulation of rats.
Eur J Clin Invest. 1994 May;24(5):320-30.

29:
Ohkura N, Inoue S, Ikeda K, Hayashi K.
Isolation and characterization of a phospholipase A2 inhibitor from the blood plasma of the Thailand cobra Naja naja kaouthia.
Biochem Biophys Res Commun. 1994 Apr 29;200(2):784-8.

30:
Sjostrom L, al-Abdulla IH, Rawat S, Smith DC, Landon J.
A comparison of ovine and equine antivenoms.
Toxicon. 1994 Apr;32(4):427-33.

31:
Barfaraz A, Harvey AL.
The use of the chick biventer cervicis preparation to assess the protective activity of six international reference antivenoms on the neuromuscular effects of snake venoms in vitro.
Toxicon. 1994 Mar;32(3):267-72.

32:
Harvey AL, Barfaraz A, Thomson E, Faiz A, Preston S, Harris JB.
Screening of snake venoms for neurotoxic and myotoxic effects using simple in vitro preparations from rodents and chicks.
Toxicon. 1994 Mar;32(3):257-65.

33:
Ferreira JP, Sasisekharan R, Louie O, Langer R.
Influence of chemistry in immobilization of cobra venom phospholipase A2: implications as to mechanism.
Biochemistry. 1993 Aug 17;32(32):8098-102.

34:
Stiles BG.
Acetylcholine receptor binding characteristics of snake and cone snail venom postsynaptic neurotoxins: further studies with a non-radioactive assay.
Toxicon. 1993 Jul;31(7):825-34.

35:
Buranasin P.
Snakebites at Maharat Nakhon Ratchasima Regional Hospital.
Southeast Asian J Trop Med Public Health. 1993 Mar;24(1):186-92.

36:
Fletcher JE, Tripolitis L, Beech J.
Species difference in modulation of calcium release by Naja naja kaouthia snake venom cardiotoxin in terminal cisternae from human and equine skeletal muscle.
Toxicon. 1993 Jan;31(1):43-51.

37:
Vernon LP, Rogers A.
Binding properties of Pyrularia thionin and Naja naja kaouthia cardiotoxin to human and animal erythrocytes and to murine P388 cells.
Toxicon. 1992 Jul;30(7):711-21.

38:
Vernon LP, Rogers A.
Effect of calcium and phosphate ions on hemolysis induced by Pyrularia thionin and Naja naja kaouthia cardiotoxin.
Toxicon. 1992 Jul;30(7):701-9.

39:
Tan NH, Swaminathan S.
Purification and properties of the L-amino acid oxidase from monocellate cobra (Naja naja kaouthia) venom.
Int J Biochem. 1992 Jun;24(6):967-73.

40:
Ortiz AR, Pisabarro MT, Gallego J, Gago F.
Implications of a consensus recognition site for phosphatidylcholine separate from the active site in cobra venom phospholipases A2.
Biochemistry. 1992 Mar 24;31(11):2887-96.

41:
Matsuda H, Ikeda Y, Kubo M.
[Pharmacological study on Naja naja kaouthia Lesson. III. Effects of 50% ethanolic extracts from liver and gall bladder on phagocytic activity of mouse reticuloendothelial system].
Yakugaku Zasshi. 1992 Mar;112(3):183-92. Japanese.

42:
Gowda DC, Davidson EA.
Structural features of carbohydrate moieties in snake venom glycoproteins.
Biochem Biophys Res Commun. 1992 Jan 15;182(1):294-301.

43:
Namiranian S, Hider RC.
Use of HPLC to demonstrate variation of venom toxin composition in the Thailand cobra venoms Naja naja kaouthia and Naja naja siamensis.
Toxicon. 1992 Jan;30(1):47-61.

44:
Fletcher JE, Jiang MS, Gong QH, Smith LA.
Snake venom cardiotoxins and bee venom melittin activate phospholipase C activity in primary cultures of skeletal muscle.
Biochem Cell Biol. 1991 Apr;69(4):274-81.

45:
da Silva Junior NJ, Griffin PR, Aird SD.
Comparative chromatography of Brazilian coral snake (Micrurus) venoms.
Comp Biochem Physiol B. 1991;100(1):117-26.

46:
Fletcher JE, Jiang MS, Gong QH, Yudkowsky ML, Wieland SJ.
Effects of a cardiotoxin from Naja naja kaouthia venom on skeletal muscle: involvement of calcium-induced calcium release, sodium ion currents and phospholipases A2 and C.
Toxicon. 1991;29(12):1489-500.

47:
Aird SD, da Silva NJ Jr.
Comparative enzymatic composition of Brazilian coral snake (Micrurus) venoms.
Comp Biochem Physiol B. 1991;99(2):287-94.

48:
Osorio e Castro VR, Ashwood ER, Wood SG, Vernon LP.
Hemolysis of erythrocytes and fluorescence polarization changes elicited by peptide toxins, aliphatic alcohols, related glycols and benzylidene derivatives.
Biochim Biophys Acta. 1990 Nov 16;1029(2):252-8.

49:
Fletcher JE, Jiang MS, Tripolitis L, Smith LA, Beech J.
Interactions in red blood cells between fatty acids and either snake venom cardiotoxin or halothane.
Toxicon. 1990;28(6):657-67.

50:
Miller RA, Tu AT.
Factors in snake venoms that increase capillary permeability.
J Pharm Pharmacol. 1989 Nov;41(11):792-4.

51:
Osorio e Castro VR, Vernon LP.
Hemolytic activity of thionin from Pyrularia pubera nuts and snake venom toxins of Naja naja species: Pyrularia thionin and snake venom cardiotoxin compete for the same membrane site.
Toxicon. 1989;27(5):511-7.

52:
Jiang MS, Fletcher JE, Smith LA.
Factors influencing the hemolysis of human erythrocytes by cardiotoxins from Naja naja kaouthia and Naja naja atra venoms and a phospholipase A2 with cardiotoxin-like activities from Bungarus fasciatus venom.
Toxicon. 1989;27(2):247-57.

53:
Jiang MS, Fletcher JE, Smith LA.
Effects of divalent cations on snake venom cardiotoxin-induced hemolysis and 3H-deoxyglucose-6-phosphate release from human red blood cells.
Toxicon. 1989;27(12):1297-305.

54:
Looareesuwan S, Viravan C, Warrell DA.
Factors contributing to fatal snake bite in the rural tropics: analysis of 46 cases in Thailand.
Trans R Soc Trop Med Hyg. 1988;82(6):930-4.

55:
Fletcher JE, Lizzo FH.
Contracture induction by snake venom cardiotoxin in skeletal muscle from humans and rats.
Toxicon. 1987;25(9):1003-10.

56:
Tsujibo H, Taniguchi T, Koyama I, Kubo M, Inamori Y.
Hypotensive compounds isolated from the dried body of Naja naja Kaouthia Lesson. I. Isolation of inosine as a hypotensive principle and structure-activity study of related compounds.
Chem Pharm Bull (Tokyo). 1986 Apr;34(4):1716-20. No abstract available.

57:
Viravan C, Veeravat U, Warrell MJ, Theakston RD, Warrell DA.
ELISA confirmation of acute and past envenoming by the monocellate Thai cobra (Naja kaouthia).
Am J Trop Med Hyg. 1986 Jan;35(1):173-81.

58:
Vogel CW, Muller-Eberhard HJ.
Cobra venom factor: improved method for purification and biochemical characterization.
J Immunol Methods. 1984 Oct 12;73(1):203-20.

59:
Evans HJ, Guthrie VH.
Proteolytic activities of cobra venoms based on inactivation of alpha 2-macroglobulin.
Biochim Biophys Acta. 1984 Jan 31;784(2-3):97-101.

60:
Teshima K, Ikeda K, Hamaguchi K, Hayashi K.
Bindings of cobra venom phospholipases A2 to micelles of n-hexadecylphosphorylcholine.
J Biochem (Tokyo). 1983 Jul;94(1):223-32.

61:
Teshima K, Ikeda K, Hamaguchi K, Hayashi K.
Participation of an ionizable group with pK 8.55 in the reaction of p-bromophenacyl bromide with His 48 of cobra venom phospholipases A2.
J Biochem (Tokyo). 1982 May;91(5):1777-88.

62:
Joubert FJ, Taljaard N.
Purification, some properties and amino-acid sequences of two phospholipases A (CM-II and CM-III) from Naja naja kaouthia venom.
Eur J Biochem. 1980 Dec;112(3):493-9.

63:
Li PL.
Cytotoxicity of cobra (Naja naja kaouthia) venom on rabbit red blood cells and S-180 tumor cells in the presence of tetracaine, lidocaine and procaine.
Z Naturforsch [C]. 1980 Mar-Apr;35(3-4):268-72.

64:
Joubert FJ, Taljaard N.
Snake venoms. The amino acid sequences of two Melanoleuca-type toxins.
Hoppe Seylers Z Physiol Chem. 1980;361(3):425-36.

65:
Joubert FJ, Taljaard N.
The complete primary structures of three cytotoxins (CM-6, CM-7 and CM-7A) from Naja naja kaouthia (Siamese cobra) snake venom.
Toxicon. 1980;18(4):455-67.